Role of bilateral adrenalectomy (and oophorectomy) in the management of patients with metastatic breast cancer.
One hundred consecutive patients who underwent bilateral adrenalectomy for metastatic breast cancer with at least a 2 year "tumor-free" interval and with symptomatic bony, local-regional, pleural, or discrete pulmonary or mediastinal metastases had objective remission rates of 65 per cent at 6 months, 48 per cent at 12 months, 28 per cent at 18 months, and 16 per cent at 24 months.
D000315:Adrenalectomy; D000328:Adult; D000367:Age Factors; D000368:Aged; D001859:Bone Neoplasms / Q000601:surgery; D001943:Breast Neoplasms / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery; D008408:Mastectomy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010053:Ovary / Q000601:surgery*; D010997:Pleural Neoplasms / Q000601:surgery